Revelation Biosciences Inc (REVB) — Capital Reinvestment Ratio
Latest as of December 2018:
0.04x
Revelation Biosciences Inc (REVB) has a Capital Reinvestment Ratio of 0.04x as of December 2018, meaning it reinvests 0% of its operating cash flow ($8.43 Million) in capital expenditures ($349.00K). See REVB cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.04x
Capex / Operating Cash Flow
Operating Cash Flow
$8.43 Million
USD
Capital Expenditures
$349.00K
USD
Data as of
Dec 2018
Most recent filing
Revelation Biosciences Inc Capital Reinvestment Ratio (2015–2019)
This chart tracks Revelation Biosciences Inc's Capital Reinvestment Ratio across 5 annual periods.
Annual Capital Reinvestment Ratio for Revelation Biosciences Inc (2015–2019)
Year-by-year Capital Reinvestment Ratio for Revelation Biosciences Inc from 2015 to 2019. For live market cap and broader valuation context, see REVB market cap overview.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.01x | $41.09 Million | $526.00K | ▼ -51.6% |
| 2018 | 0.03x | $32.58 Million | $861.00K | ▼ -20.3% |
| 2017 | 0.03x | $24.25 Million | $804.00K | ▼ -33.9% |
| 2016 | 0.05x | $11.60 Million | $582.00K | ▲ +0.0% |
| 2015 | 0.05x | $11.60 Million | $582.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow